Edmond DE Rothschild Holding S.A. decreased its position in Perrigo Company plc (NYSE:PRGO – Free Report) by 0.8% in the 4th quarter, Holdings Channel.com reports. The fund owned 1,215,000 shares of the company’s stock after selling 10,000 shares during the period. Edmond DE Rothschild Holding S.A.’s holdings in Perrigo were worth $31,238,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other institutional investors have also made changes to their positions in PRGO. Wellington Management Group LLP increased its stake in Perrigo by 229.2% during the third quarter. Wellington Management Group LLP now owns 2,697,698 shares of the company’s stock valued at $70,761,000 after purchasing an additional 1,878,145 shares during the last quarter. FMR LLC grew its position in shares of Perrigo by 66,795.3% during the 3rd quarter. FMR LLC now owns 1,840,289 shares of the company’s stock valued at $48,271,000 after buying an additional 1,837,538 shares during the last quarter. Norges Bank acquired a new stake in Perrigo during the fourth quarter worth about $36,614,000. Bahl & Gaynor Inc. lifted its holdings in Perrigo by 44.9% in the fourth quarter. Bahl & Gaynor Inc. now owns 1,525,197 shares of the company’s stock worth $39,213,000 after acquiring an additional 472,958 shares during the last quarter. Finally, Access Investment Management LLC acquired a new position in Perrigo in the fourth quarter valued at approximately $7,989,000. 95.91% of the stock is currently owned by institutional investors.
Insider Buying and Selling at Perrigo
In other news, EVP Ronald Craig Janish sold 7,800 shares of the firm’s stock in a transaction dated Monday, March 10th. The shares were sold at an average price of $27.44, for a total transaction of $214,032.00. Following the completion of the transaction, the executive vice president now owns 33,666 shares in the company, valued at approximately $923,795.04. This trade represents a 18.81 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. 0.70% of the stock is currently owned by corporate insiders.
Analysts Set New Price Targets
Get Our Latest Stock Report on Perrigo
Perrigo Trading Up 1.1 %
Shares of PRGO stock opened at $28.06 on Monday. The firm has a market capitalization of $3.83 billion, a PE ratio of -23.98 and a beta of 0.48. The company has a debt-to-equity ratio of 0.94, a quick ratio of 1.77 and a current ratio of 2.56. Perrigo Company plc has a 1 year low of $23.14 and a 1 year high of $33.46. The stock has a fifty day moving average of $26.11 and a two-hundred day moving average of $26.15.
Perrigo (NYSE:PRGO – Get Free Report) last announced its earnings results on Thursday, February 27th. The company reported $0.93 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.92 by $0.01. The firm had revenue of $1.14 billion during the quarter, compared to analyst estimates of $1.20 billion. Perrigo had a negative net margin of 3.64% and a positive return on equity of 7.38%. As a group, research analysts expect that Perrigo Company plc will post 2.56 EPS for the current year.
Perrigo Increases Dividend
The company also recently announced a quarterly dividend, which was paid on Tuesday, March 25th. Shareholders of record on Friday, March 7th were given a $0.29 dividend. This represents a $1.16 dividend on an annualized basis and a yield of 4.13%. This is an increase from Perrigo’s previous quarterly dividend of $0.28. The ex-dividend date was Friday, March 7th. Perrigo’s dividend payout ratio is -92.80%.
Perrigo Company Profile
Perrigo Company plc provides over-the-counter health and wellness solutions to enhance individual well-being in the United States, Europe, and internationally. It operates through Consumer Self-Care Americas and Consumer Self-Care International segments. The company develops, manufactures, markets, and distributes self-care consumer products, such as upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and nutritional beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers.
See Also
- Five stocks we like better than Perrigo
- What Are Earnings Reports?
- Venezuelan Tariffs Could Power These 3 Diesel-Driven Winners
- How to Buy Gold Stock and Invest in Gold
- MarketBeat Week in Review – 03/24 – 03/28
- Insider Selling Explained: Can it Inform Your Investing Choices?
- Should You Buy UPS Stock Now? Deep Dive Into Its 5-Year Low
Want to see what other hedge funds are holding PRGO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Perrigo Company plc (NYSE:PRGO – Free Report).
Receive News & Ratings for Perrigo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Perrigo and related companies with MarketBeat.com's FREE daily email newsletter.